Effect of Coenzyme Q10 on oxidative stress, glycemic control and inflammation in diabetic neuropathy: A double blind randomized clinical Trial

International Journal for Vitamin and Nutrition Research

Volumn 84, Issue 5-6, 2014, Pages 252-260

  Fakhrabadi, Maryam Akbari ^a   Ghotrom, Ahmad Zeinali ^a   Mozaffari Khosravi, Hassan ^a   Nodoushan, Hossein Hadi ^a   Nadjarzadeh, Azadeh ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood glucose; Diabetic neuropathy; Insulin sensitivity; Lipid profi le; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; UBIDECARENONE; GLUCOSE BLOOD LEVEL; UBIQUINONE;

ADULT; AGED; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; TOTAL ANTIOXIDANT CAPACITY; ANALOGS AND DERIVATIVES; DIABETIC NEUROPATHIES; DRUG EFFECTS; MIDDLE AGED;

BLOOD GLUCOSE; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; UBIQUINONE;

EID: 84939125822     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000211     Document Type: Article

References (36)

1. Piconi, L., Quagliaro, L., Ceriello, A. (2005) Oxidative Stress in Diabetes. Clinical Chemistry and Laboratory Medicine. 41 (9): 1144 - 9.
2. Fowler, M. J. (2011) Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes. 29, 116 - 22.
3. Feldman, E.L. (2003) Oxidative stress and diabetic neuropathy: a new understanding of an old problem. Journal of Clinical Investigation, 111, 431 - 3.
4. Boulton, A.J., Vinik, A.I., Arezzo, J.C., et al. (2005) Diabetic neuropathies a statement by the American Diabetes Association. Diabetes Care, 28, 956 - 62.
5. Bradley, W. G., Daroff R. B., Fenichel, G. M., et al. (2008) Neurology in clinical practice. Fifth ed. Philadelphia: Butterworth Heinemann. p. 2310.
6. Pop-Busui, R., Lu, J., Lopes, N., et al. (2009) Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. Journal of the Peripheral Nervous System. 14, 1 - 13.
7. Figueroa-Romero, C., Sadidi, M., Feldman, E.L. (2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine and Metabolic Disorders. 9, 301 - 14.
8. Maritim, A., Sanders, R., Watkins, R.J. (2003) Diabetes, oxidative stress, and antioxidants: a review. Journal of biochemical and molecular toxicology. 17, 24 - 38.
9. Kaikkonen, J., Tuomainen, T-P., Nyyssönen, K., et al. (2002) Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free radical research. 36, 389 - 97.
10. Rosenfeldt, F., Haas, S., Krum, H., et al. (2007) Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of human hypertension. 21, 297 - 306.
11. Gao, L., Mao, Q., Cao, J., et al. (2012) Effects of coenzyme Q10 on vascular endothelial function in humans: A meta-analysis of randomized controlled trials. Atherosclerosis. 221, 311 - 6.
12. Mezawa, M., Takemoto, M., Onishi, S., et al. (2012) The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study. Biofactors. 38, 416 - 21.
13. Zhang, Y.P., Eber, A., Yuan, Y., et al. (2013) Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Anesthesiology. 118, 945 - 54.
14. Crane, F.L. (2001)Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition. 20, 591 - 8.
15. Chew, G., Watts, G. (2004) Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'. Qjm. 97, 537 - 48.
16. M Victor, V., Rocha, M., Herance, R., et al. (2011) Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Current pharmaceutical design. 17, 3947 - 58.
17. El-ghoroury, E.A., Raslan, H.M., Badawy, E.A., et al. (2009) Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus:correlation with glycemic control. Blood Coagulation & Fibrinolysis. 20, 248 - 51.
18. Singh, R.B., Niaz, M.A., Rastogi, S.S., et al. (1999) Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 13, 203 - 208.
19. Hodgson, J.M., Watts, G.F., Playford, D.A., et al. (2002) Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 56, 1137 - 42.
20. Shargorodsky, M., Debby, O., Matas, D., et al. (2010) Effect of long-term treatment with antioxidants(vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutrition & Metabolism. 7, 55.
21. Modi, K., Vishkarma, S., Goyal, R.K., et al. (2006) Beneficial Effects of Coenzyme Q10 in Streptozotocin-Induced Type I Diabetic Rats. IJPT 5, 61 - 6.
22. Sharma. A., Kharb. S., Chugh. S.N., et al. (2000) Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 49, 160 - 162.
23. Lee, B., Huang, Y., Chen, S. (2012) Effects of coenzyme Q10 supplementation on inflammatory markers(high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 28, 767 - 72.
24. Hernández-Ojeda, J., Cardona-Muñoz, E.G., Román-Pintos, L.M., et al. (2012) The effect of ubiquinone in diabetic polyneuropathy: A randomized double-blind placebo-controlled study. Journal of diabetes and its complications. 26, 352 - 8.
25. Evans, J.L., Goldfine, I.D., Maddux, B.A., et al. (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine reviews. 23, 599 - 622.
26. Damasceno, D.C., Volpato, G.T., Paranhos Calderon I.D.M., et al. (2002) Oxidative stress and diabetes in pregnant rats. Animal reproduction science. 72, 235 - 44.
27. Davì, G., Falco, A., Patrono, C. ( 2005) Lipid peroxidation in diabetes mellitus. Antioxidants & redox signaling. 7, 256 - 68.
28. Memisoğullari, R., Taysi, S., Bakan, E., et al. (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell biochemistry and function. 21, 291 - 6.
29. Ziegler, D., Nowak, H., Kempler, P., et al. (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a meta-analysis. Diabetic Medicine. 21, 114 - 21.
30. Ziegler, D., Low, P.L., Litchy, W.J., et al. (2011) Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over4 Years in Diabetic Polyneuropathy. Diabetes Care. 34, 2054 - 60.
31. Tutuncu, N.B., Bayraktar, M., Varli, K. (1998) Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care.11, 1915 - 8.
32. Papucci, L., Schiavone, N., Witort, E., et al. (2003) Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. Journal of Biological Chemistry. 278, 28220 - 8.
33. Shi, T.J.S., Zhang, M.D., Zeberg, H., et al. (2013) Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proceedings of the National Academy of Sciences. 110, 690 - 5.
34. Kandhare, A.D., Ghosh, P., Ghule, A.E., et al. (2013) Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcoholinduced neuropathic pain. Fundamental & clinical pharmacology. 27, 603 - 22.
35. Zhang, Y.P., Song, C.Y., Yuan, Y., et al. (2013) Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. Neurobiology of disease. 58, 169 - 78.
36. Vinik, A.I., Maser, R.E., Mitchell, B.D., et al. (2003) Diabetic autonomic neuropathy. Diabetes care. 26, 1553 - 79.